Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $5.37 Million - $5.9 Million
-28,607 Reduced 65.27%
15,225 $2.93 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $102,327 - $162,870
802 Added 1.86%
43,832 $8.88 Million
Q4 2022

Feb 14, 2023

SELL
$117.37 - $139.17 $1.37 Million - $1.63 Million
-11,692 Reduced 21.37%
43,030 $5.53 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $1 Million - $1.33 Million
-7,396 Reduced 11.91%
54,722 $7.49 Million
Q2 2022

Aug 15, 2022

BUY
$108.81 - $179.33 $1.5 Million - $2.48 Million
13,810 Added 28.59%
62,118 $11 Million
Q1 2022

May 16, 2022

BUY
$119.61 - $157.85 $2.08 Million - $2.74 Million
17,373 Added 56.16%
48,308 $6.96 Million
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $9,267 - $12,405
-65 Reduced 0.21%
30,935 $4.78 Million
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $121,509 - $144,856
853 Added 2.83%
31,000 $5.26 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $145,886 - $173,988
1,080 Added 3.72%
30,147 $4.76 Million
Q1 2021

May 14, 2021

BUY
$137.51 - $190.8 $1.21 Million - $1.68 Million
8,798 Added 43.41%
29,067 $4.04 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $3.34 Million - $4.3 Million
20,269 New
20,269 $3.55 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.